MiNK Therapeutics News - INKT

Company Name	Stock Ticker Symbol	Market	Type
MiNK Therapeutics Inc	INKT	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.043	4.94%	0.9142	16:06:36

Open Price	Low Price	High Price	Close Price	Prev Close
0.90	0.88115	0.929999	0.9142	0.8712

more quote information »

Recent News

Date	Time	Source	Heading
4/08/2024	12:00	GLOBE	MiNK Therapeutics Announces Promising Preclinical Activity..
3/21/2024	07:26	IHMARKETNEWS	U.S. Index Futures Rise as Fed’s Dovish Outlook Spurs..
3/21/2024	07:00	GLOBE	MiNK Reports Fourth Quarter and Year-End 2023 Results
3/07/2024	07:30	GLOBE	MiNK to Provide Corporate Update and Fourth Quarter & Full..
3/05/2024	18:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/29/2024	16:05	EDGAR2	Form 8-K - Current report
2/14/2024	08:00	EDGAR2	Form 8-K - Current report
2/14/2024	08:00	GLOBE	First Refractory Gastric Cancer Patient Dosed in Phase 2..
2/06/2024	08:00	GLOBE	MiNK Therapeutics' AgenT-797 Shows Promising Results in the..
1/30/2024	08:00	GLOBE	MiNK’s AgenT-797 Offers New Hope in Overcoming ICI..
1/18/2024	20:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/20/2023	07:30	GLOBE	ImmunoScape and MiNK Therapeutics Collaborate to Accelerate..
12/05/2023	18:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/09/2023	07:00	EDGAR2	Form 8-K - Current report
11/09/2023	07:00	GLOBE	MiNK Therapeutics Reports Third Quarter 2023 Results
11/03/2023	12:00	GLOBE	MiNK Therapeutics Presents Clinical Activity and Long-Term..
10/30/2023	08:00	GLOBE	MiNK to Provide Third Quarter 2023 Financial Report and..
10/17/2023	16:15	EDGAR2	Form 8-K - Current report
9/27/2023	09:05	GLOBE	MiNK Therapeutics To Present Data Update From Allogeneic..
9/06/2023	17:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/06/2023	17:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/24/2023	08:30	GLOBE	MiNK Therapeutics to Participate in September Investor..
8/11/2023	07:44	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
8/10/2023	07:30	EDGAR2	Form 8-K - Current report
8/10/2023	07:30	GLOBE	MiNK Therapeutics Reports Second Quarter 2023 Results
8/10/2023	07:26	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/28/2023	08:30	GLOBE	MiNK to Provide Second Quarter 2023 Financial Report and..
6/05/2023	07:30	GLOBE	MiNK Therapeutics Announces Virtual Annual Shareholders..
5/22/2023	08:30	GLOBE	MiNK Presents Clinical Data on Allogeneic iNKT Cells..
5/18/2023	08:30	GLOBE	MiNK's Novel FAP-CAR-iNKT Presented at ASGCT
5/11/2023	08:00	GLOBE	MiNK Therapeutics Reports Corporate Update and First Quarter..
4/27/2023	08:30	GLOBE	MiNK Therapeutics to Report First Quarter 2023 Corporate..